18.11.2014 Views

09/2009 - Državni zavod za intelektualno vlasništvo

09/2009 - Državni zavod za intelektualno vlasništvo

09/2009 - Državni zavod za intelektualno vlasništvo

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

3518 HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601<br />

MKP Broj objave europske Naziv izuma<br />

prijave patenta<br />

(51) (97) (54)<br />

A61P 35/00 (2006.01) EP 2<strong>09</strong>9803 * HETEROBICYCLIC MATRIX METALLOPROTEASE INHIBITORS<br />

A61P 35/00 (2006.01) EP 2<strong>09</strong>9827 * ANTAGONIST ANTI-NOTCH3 ANTIBODIES AND THEIR USE IN THE PREVENTION AND<br />

TREATMENT OF NOTCH3-RELATED DISEASES<br />

A61P 35/02 (2006.01) EP 2089027 * USE OF IAP INHIBITORS FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA<br />

A61P 35/02 (2006.01) EP 2<strong>09</strong>8595 * HLA-A*1101-RESTRICTED WT1 PEPTIDE AND PHARMACEUTICAL COMPOSITION<br />

COMPRISING THE SAME<br />

A61P 35/02 (2006.01) EP 2<strong>09</strong>9451 * COMBINATION OF AN HDAC INHIBITOR AND AN ANTIMETABOLITE<br />

A61P 35/04 (2006.01) EP 2089392 * 3-(DIHYDRO-1H-PYRAZOLO Ý4,3-D¨PYRIMIDIN-5-YL)-4-<br />

PROPOXYBENZENESULFONAMIDE DERIVATIVES AND METHODS OF USE<br />

A61P 37/00 (2006.01) EP 2<strong>09</strong>1949 * INDOLE DERIVATIVES AS S1P1 RECEPTOR AGONISTS<br />

A61P 37/00 (2006.01) EP 2<strong>09</strong>1950 * OXADIAZOLE DERIVATIVES AS S1P1 RECEPTOR AGONISTS<br />

A61P 37/00 (2006.01) EP 2<strong>09</strong>3228 * PYRROLINE-2-ONE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS<br />

FACTOR, PREPARATION METHODS AND USES THEREOF<br />

A61P 37/00 (2006.01) EP 2<strong>09</strong>7455 * HUMANIZED ANTI-FACTOR D ANTIBODIES<br />

A61P 37/04 (2006.01) EP 2087103 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />

A61P 37/04 (2006.01) EP 2089514 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />

A61P 37/04 (2006.01) EP 2<strong>09</strong>2058 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />

A61P 37/06 (2006.01) EP 2014653 Novel dicarboxylic acid derivatives as S1P1 receptor agonists<br />

A61P 37/06 (2006.01) EP 2<strong>09</strong>7529 * METHODS OF SELECTING AND PRODUCING MODIFIED TOXINS, CONJUGATES<br />

CONTAINING MODIFIED TOXINS AND USES THEREOF<br />

A61P 37/08 (2006.01) EP 2086569 * USE OF THYMOSIN ALPHA 1 FOR THE PREPARATION OF A MEDICAMENT FOR THE<br />

PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASES<br />

A61P 39/00 (2006.01) EP 2<strong>09</strong>4265 * PYRROLOY[1,2-A]IMIDAZOLEDIONE EFFECTIVE IN THE TREATMENT OF PERIPHERAL<br />

NEUROTOXICITY INDUCED BY CHEMOTHERAPEUTIC AGENTS<br />

A61P 43/00 (2006.01) EP 2<strong>09</strong>4672 * ARYLSULFONAMIDE COMPOUNDS<br />

A61P 43/00 (2006.01) EP 2<strong>09</strong>6111 * PYRAZOLES AND USE THEREOF AS DRUGS<br />

A61P 43/00 (2006.01) EP 2<strong>09</strong>6167 * APTAMER AGAINST MIDKINE AND USE THEREOF<br />

A61P 5/00 (2006.01) EP 2<strong>09</strong>3228 * PYRROLINE-2-ONE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS<br />

FACTOR, PREPARATION METHODS AND USES THEREOF<br />

A61P 5/00 (2006.01) EP 2<strong>09</strong>7420 * SPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS<br />

A61P 5/32 (2006.01) EP 1935415 Treatment of androgen-deprivation induced osteoporosis<br />

A61P 5/44 (2006.01) EP 2<strong>09</strong>1922 * 2-[1-PHENYL-5-HYDROXY-4ALPHA-METHYL-HEXAHYDROCYCLOPENTA[F]INDAZOL-5-<br />

YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS<br />

A61P 5/44 (2006.01) EP 2<strong>09</strong>7385 * HEXAHYDROCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS<br />

GLUCOCORTICOID RECEPTOR LIGANDS<br />

2-[1-PHENYL-5-HYDROXY OR METHOXY-4ALPHA-METHYL-<br />

A61P 7/00 (2006.01) EP 2089041 * METHODS FOR USING ALDHBR CELLS TO SUPPLEMENT STEM CELL<br />

TRANSPLANTATION<br />

A61P 7/00 (2006.01) EP 2<strong>09</strong>7108 * FACTOR IX MOIETY-POLYMER CONJUGATES HAVING A RELEASEABLE LINKAGE<br />

A61P 7/02 (2006.01) EP 2014296 Novel strategies for increasing the reperfusion in obstructed blood vessel<br />

A61P 7/02 (2006.01) EP 2<strong>09</strong>4272 * NITROGEN CONTAINING SUBSTITUTED HETEROCYCLES AS PLATELET ADP RECEPTOR<br />

INHIBITORS<br />

A61P 7/02 (2006.01) EP 2<strong>09</strong>7390 * AMINO QUINAZOLINES DERIVATIVES WUTH BLOOD PLATELET REDUCING PROPERTIES<br />

A61P 7/02 (2006.01) EP 2<strong>09</strong>9750 * NEW CRYSTALLINE FORMS<br />

A61P 7/06 (2006.01) EP 2089041 * METHODS FOR USING ALDHBR CELLS TO SUPPLEMENT STEM CELL<br />

TRANSPLANTATION<br />

A61P 9/00 (2006.01) EP 2086535 * ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE TREATMENT OF SYSTEMIC<br />

DISEASES IN CATS<br />

A61P 9/00 (2006.01) EP 2<strong>09</strong>3228 * PYRROLINE-2-ONE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS<br />

FACTOR, PREPARATION METHODS AND USES THEREOF<br />

A61P 9/00 (2006.01) EP 2<strong>09</strong>6167 * APTAMER AGAINST MIDKINE AND USE THEREOF<br />

A61P 9/00 (2006.01) EP 2<strong>09</strong>7079 * MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS<br />

A61P 9/00 (2006.01) EP 2<strong>09</strong>9448 * PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF<br />

RESTENOSIS<br />

A61P 9/02 (2006.01) EP 2<strong>09</strong>7378 * NOVEL SEH INHIBITORS AND THEIR USE<br />

A61P 9/04 (2006.01) EP 2086533 * USE OF AN ADENOSINE ANTAGONIST<br />

A61P 9/04 (2006.01) EP 2<strong>09</strong>4271 * DRUG COMBINATIONS FOR TREATING AIRWAY DISEASES<br />

A61P 9/04 (2006.01) EP 2<strong>09</strong>7378 * NOVEL SEH INHIBITORS AND THEIR USE<br />

A61P 9/06 (2006.01) EP 2<strong>09</strong>4271 * DRUG COMBINATIONS FOR TREATING AIRWAY DISEASES<br />

A61P 9/08 (2006.01) EP 2<strong>09</strong>1537 * PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CAPILLARY<br />

ARTERIOPATHY<br />

A61P 9/10 (2006.01) EP 2014296 Novel strategies for increasing the reperfusion in obstructed blood vessel<br />

A61P 9/10 (2006.01) EP 2<strong>09</strong>1531 * PHENYL SUBSTITUTED MALEIMIDES AS MEDICAMENTS FOR BLOCKING<br />

DEGENERATIVE TISSUE DAMAGES BY INHIBITING MPT<br />

A61P 9/10 (2006.01) EP 2<strong>09</strong>1534 * AZETIDINONE DERIVATIVES AND METHODS OF USE THEREOF<br />

A61P 9/10 (2006.01) EP 2<strong>09</strong>1537 * PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CAPILLARY<br />

ARTERIOPATHY<br />

A61P 9/10 (2006.01) EP 2<strong>09</strong>3228 * PYRROLINE-2-ONE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS<br />

FACTOR, PREPARATION METHODS AND USES THEREOF<br />

ISSN 1331-2030

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!